Target
HDAC10
1 abstract
Abstract
Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for human uterine sarcoma cells.Org: Cancer Biology Department, National Cancer Institute, Vilnius, Lithuania, Cairo University, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China, University of Chicago,